Extended adjuvant temozolomide improves survival in a glioblastoma mouse model

被引:0
|
作者
Wang, Hanxiao [1 ]
Al-Holou, Wajd [1 ]
Heist, Kevin [1 ]
Galban, Craig J. [1 ]
deCarvalho, Ana C. [2 ]
Mikkelsen, Tom [2 ]
Ross, Brian D. [1 ]
Rehemtulla, Alnawaz [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
关键词
D O I
10.1158/1538-7445.AM2014-2061
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2061
引用
收藏
页数:2
相关论文
共 50 条
  • [41] RETROSPECTIVE EVALUATION OF OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN PATIENTS WITH GLIOBLASTOMA COMPARING 6 VS 12 CYCLES OF ADJUVANT TEMOZOLOMIDE
    Perez, D. Martinez
    Mendez, B. Deben
    Roldan, M. Rodriguez
    Botella, M. Garrido
    Cuesta, J. Garcia
    Barbas, J. Pedregosa
    Aguirre, Y. Vilches
    Marin, V. Martinez
    NEURO-ONCOLOGY, 2022, 24
  • [42] Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis
    Gutenberg, A.
    Bock, H. C.
    Reifenberger, G.
    Brueck, W.
    Giese, A.
    ACTA NEUROCHIRURGICA, 2013, 155 (03) : 429 - 435
  • [43] Benefit of a prolonged adjuvant treatment with temozolomide for the management of patients with glioblastoma
    Malkoun, N.
    Fotso, M. -J.
    Cartier, L.
    Forest, F.
    Auberdiac, P.
    Chargari, C.
    Thorin, J.
    Pacaut, C.
    Peoc'h, M.
    Nuti, C.
    Schmitt, T.
    Magne, N.
    CANCER RADIOTHERAPIE, 2011, 15 (03): : 202 - 207
  • [44] Optimal duration of adjuvant temozolomide in glioblastoma: An unsolved and unsolvable problem
    Balana, Carmen
    NEURO-ONCOLOGY PRACTICE, 2022, 9 (05) : 349 - 350
  • [45] Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis
    A. Gutenberg
    H. C. Bock
    G. Reifenberger
    W. Brück
    A. Giese
    Acta Neurochirurgica, 2013, 155 : 429 - 435
  • [46] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
    Minniti, G.
    De Sanctis, V.
    Muni, R.
    Filippone, F.
    Bozzao, A.
    Valeriani, M.
    Osti, M. F.
    De Paula, U.
    Lanzetta, G.
    Tombolini, V.
    Enrici, R. Maurizi
    JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (01) : 97 - 103
  • [47] Pediatric glioblastoma: Results with adjuvant chemoradiation using temozolomide.
    Joshi, Nikhil Purushottam
    Mallick, Supriya
    Gandhi, Ajeet
    Goyal, Shikha
    Puri, Tarun
    Julka, Pramod Kumar
    Sharma, Dayanand
    Rath, Goura Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Radiotherapy plus adjuvant temozolomide for the treatment of glioblastoma - a paradigm shift
    Fine, HA
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (07): : 334 - 335
  • [49] THE IMPACT OF THROMBOCYTOPENIA FROM CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH GLIOBLASTOMA
    Nivet, A.
    Schernberg, A.
    Louvel, G.
    Dumont, S.
    Ammary, S.
    Rehalia-Blanchard, A.
    Clavere, P.
    Parker, F.
    Pallud, J.
    Dhermain, F.
    NEURO-ONCOLOGY, 2018, 20 : 228 - 229
  • [50] The duration of adjuvant temozolomide in patients with glioblastoma and the law of diminishing returns
    Grossman, Stuart A.
    NEURO-ONCOLOGY, 2020, 22 (12) : 1721 - 1722